Trial intelligence / Profile preview

NPC-02 Dose Adjustment in Zinc Deficiency

NCT02321865Phase 3Completed

Sponsor
Nobelpharma Co., Ltd.
Start
Jan 2015
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zinc acetate in zinc deficiency, sponsored by Nobelpharma Co., Ltd.. Started Jan 2015; status: completed.

02

Drugs

zinc acetate
03

Conditions

zinc deficiency

Beyond the preview

Go deeper on NCT02321865.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02321865.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call